Improve the Treatment of Thoracic Esophageal Cancer
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is
1. To compare the effects of the two types of thoracic esophageal cancer lymphadenectomy on
the staging and prognosis of resectable esophageal cancer, which defined by the
International Association of esophageal disease(ISDE) - standard mediastinal
lymphadenectomy,total mediastinal lymphadenectomy and three field lymphadenectomy,and to
find out reasonable range of lymphadenectomy.
2. To compare the effects of Chemotherapy Group (Docetaxel + Nedaplatin) with Control Group
on the prognosis of resectable thoracic esophageal cancer,and to explore the indications
of adjuvant chemotherapy.